Science & Enterprise subscription

Follow us on Twitter

  • As the race to produce and distribute Covid-19 vaccines intensifies, financing of this global public health project… https://t.co/pyDX0IWnCs
    about 5 hours ago
  • New post on Science and Enterprise: Infographic – Public Money Funds Covid-19 Vaccines https://t.co/1D2XLhUi4Z #Science #Business
    about 5 hours ago
  • Excellent analysis. Real example: a colleague I hired at Science mag is leaving her job to get a grad degree in IT. https://t.co/c0qnYW025H
    about 8 hours ago
  • Two biotechnology companies are collaborating on using the gene editing technique Crispr to create engineered immun… https://t.co/4lK4qD5p6m
    about 1 day ago
  • New post on Science and Enterprise: Biotechs Partner on Gene-Edited Cancer Cell Therapies https://t.co/ck7tBkXfXF #Science #Business
    about 1 day ago

Please share Science & Enterprise

Essay – Find the Missing Vaccine Doses

Syringes for disposal

Biden’s vaccine distribution team needs to find those doses, and fast, before their shelf life expires. . . . → Read More: Essay – Find the Missing Vaccine Doses

Essay – Enlist U.S. Retailers for Vaccine Distribution

A promising solution for vaccine distribution is staring policy-makers in the face, on street corners and shopping centers across the U.S., retail chain stores. . . . → Read More: Essay – Enlist U.S. Retailers for Vaccine Distribution

Women’s Heart Health Diagnostics in the Works

Heart health

An organization for redressing health disparities faced by women awarded a new grant to advance better tools for predicting risk of women’s heart disease. . . . → Read More: Women’s Heart Health Diagnostics in the Works

Essay – Ten Years and Counting

4th of July fireworks

If you dig deep into the Science & Enterprise archives, you’ll find this site began posting on 6 July 2010, exactly 10 years ago today. . . . → Read More: Essay – Ten Years and Counting

Editorial – No More Business as Usual

Protest sign

As much as Science & Enterprise tries to stick to its reporting of science news for business people, and enterprise for scientists, sometimes events of the day overtake our usual news topics. . . . → Read More: Editorial – No More Business as Usual

Commentary – Biotech, Trump’s Latest Casino

SARS-Cov-2 virus

If you thought the Trump administration couldn’t bungle any worse its response to the coronavirus pandemic, think again. . . . → Read More: Commentary – Biotech, Trump’s Latest Casino

Int’l Group Funding Coronavirus Vaccines

Health screening Shanghai

An international health coalition is funding development of vaccines against the new coronavirus outbreak spreading quickly through China and to other countries. . . . → Read More: Int’l Group Funding Coronavirus Vaccines

Commentary – New Models Needed for Antibiotic Resistance

MRSA bacteria

Many parts of a new model for fighting antibiotic resistance are in development, and the pieces still need to be assembled, but the outline of a precision-medicine rather than mass-produced drug model is beginning to emerge. . . . → Read More: Commentary – New Models Needed for Antibiotic Resistance

FDA Chief Calls Teen Vaping an “Epidemic”

Scott Gottlieb at Brookings Institution

The commissioner of the Food and Drug Administration warned that the sharp rise in teen electronic cigarette use is an epidemic threatening the public health. . . . → Read More: FDA Chief Calls Teen Vaping an “Epidemic”

Insulin Delivered by Capsule, That’s the Good News

Diabetes word cloud

Before we start celebrating the end of injections, we need to deal with a more basic problem facing people with diabetes, namely the rapidly rising cost of insulin. . . . → Read More: Insulin Delivered by Capsule, That’s the Good News